Clinic-based infant screening for duchenne muscular dystrophy: a feasibility study

Abstract

Purpose. The purpose of this study was to assess the desirability of Duchenne muscular dystrophy (DMD) screening, the effectiveness of the consent process, and the feasibility of conducting DMD screening in a pediatric office. Methods. Infant males who attended a 12-month routine well-child visit at a participating pediatric clinic were screened for DMD. Parents and providers completed post-screening questionnaires to assess their experiences with and attitudes toward screening. Results. A total of 264 male infants were screened for DMD. Approximately 78% of parents indicated support of voluntary DMD screening and 91% of providers were in favor of screening for DMD. About 75% of parents correctly answered three of five questions testing their knowledge of DMD screening. Conclusion. DMD screening is feasible in a pediatric office when conducted as part of a research study. Infant screening for DMD eventually could be offered in pediatric health care provider offices as an optional public health service outside of newborn screening.

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Survey A, Page 1

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Survey A, Page 2

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Survey A, Page 3

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Survey A, Page 4

Infant Screening for Duchenne Muscular Dystrophy (DMD) -Survey C, Page 1

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Survey C, Page 2

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Healthcare Provider Survey, Page 1

Infant Screening for Duchenne Muscular Dystrophy (DMD) - Healthcare Provider Survey, Page 2